TechnipFMC is a global leader in oil and gas projects, technologies, systems and services with one overriding vision: to enhance the performance of the world’s energy industry. Our vision is supported by utmost dedication and expertise of 40,000 plus talented employees present in 48 countries. With proprietary technologies and production systems, integrated expertise and comprehensive solutions, we are transforming our clients’ project economics across subsea, onshore/offshore and surface. To know more about us, click here
In India, we bring in strong expertise in the field of Onshore – Refining, Petrochemicals, LNG, Fertilizers, Oil & Gas; Offshore – Process Platform and Subsea Engineering.
Growing strong with 2500 plus people in three operating centers in Delhi, Mumbai and Chennai, TechnipFMC in India built itself a reputation as a one-stop consultancy and EPC project organization committed to deliver challenging and exciting projects for the energy industry. We are capable of providing a complete range of services from licensing, PMC services, FEED, basic engineering to full EPC projects – ‘Concept to Commissioning’. We have a strong presence as a Tier 1 EPC player serving the Oil & Gas (upstream & downstream), refinery, petrochemicals, fertilizers, chemicals, LNG, with proprietary technologies e.g. hydrogen, ethylene and supply of process driven products like heaters and reformers.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8250851-technipfmc-celebrating-46-years-india/
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
To view the multimedia release go to:
https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
Vigilant Solutions, a global intelligence and analytics company serving law enforcement agencies, announced today BallisticSearch™, a new product providing law enforcement agencies with faster and more efficient cartridge case analysis, will be unveiled at the upcoming International Association of Chiefs of Police Conference, October 21st – 24th in Philadelphia. BallisticSearch includes portable image capture hardware, cartridge case capture software and ballistics comparison technology. The solution enables agencies to quickly compare evidence from crime scenes to help generate more investigative leads, and potentially identify more suspects and the firearms they use.
Developed using the company’s image analysis and technology expertise, BallisticSearch is designed to be the most efficient system available for analyzing ballistic evidence in both 2D and 3D format. BallisticSearch can process evidence in minutes, while other systems can take hours to process the same evidence. BallisticSearch’s faster analysis will have a huge impact on reducing backlogs. With faster comparisons and potential links established, agencies can generate strong investigative leads boosting their ability to solve crimes more quickly, in some cases right from the crime scene. This will help agencies establish a comprehensive ballistic collection program and ultimately reduce crime rates.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134351-vigilant-solutions-ballisticsearch-faster-analysis/
A new online resource is now available to help people recognize and find high quality care for alcohol use disorder, which affects more than 15 million adults in the United States. The Alcohol Treatment Navigator, designed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, is a comprehensive, yet easy-to-use tool to help individuals and their loved ones navigate the often-complicated process of choosing treatment for alcohol problems. With many treatment options available, the navigator makes the search easier by telling them what they need to know - and what they need to do – to find appropriate, quality care.
“We developed this tool to help address the alcohol ‘treatment gap,’” said NIAAA Director George F. Koob, Ph.D. “In any given year, less than 10 percent of individuals diagnosed with alcohol use disorder receive treatment, and many of them do not receive the type of care that best fits their needs. A big reason for that, we believe, is that people with alcohol use disorder often don’t know where to turn for help. The Alcohol Treatment Navigator offers a comprehensive strategy to help people search for professionally-led, evidence-based alcohol treatment, which should improve their chances for success.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8179051-niaaa-alcohol-treatment-navigator/
FAIR Health has launched a groundbreaking website, YouCanPlanForThis.org, aimed at transforming how people in New York State engage in healthcare planning. A next-generation transparency tool, the free site gives New Yorkers unprecedented access to accurate medical and dental costs and comprehensive educational resources, so they can plan financially for a procedure or episode of care. A national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information, FAIR Health developed YouCanPlanForThis.org by building on its existing, award-winning consumer website and mobile app, with the support of the New York State Health Foundation (NYSHealth).
To view the multimedia release go to:
https://www.multivu.com/players/English/8087151-fair-health-youcanplanforthis-healthcare-planning/
Attention moms, dads, grandmas, grandpas and everyone in between: Toys“R”Us® today unveiled its 2017 Holiday Hot Toy List. As the leading expert on all things toy, the Toys“R”Us team has traveled the world over the past two decades to uncover hot trends and toy phenomena like Tickle Me™ Elmo, Zhu Zhu Pets®, Hatchimals™ and more, so they can provide parents and gift-givers with the inside scoop on kids’ most-wanted playthings. This year’s list is no exception, featuring items from Hatchimals Surprise™ to PAW Patrol Sea Patroller™ and more than 20 items available exclusively at Toys“R”Us (cue Luke Skywalker’s Landspeeder™). Eager holiday shoppers can rest easy knowing they can get the comprehensive list of this year’s 50 hottest toys at Toysrus.com/HotToys.
“At Toys“R”Us, it’s serious business deciding which toys make the cut and end up on our Holiday Hot Toy List, ” said Ariana Gentry, Toys“R”Us President of Play. “Not only is this year’s list filled with ultra-hot and kid-approved gifts – but I can personally say that each of these toys are super FUN to play with!”
To view the multimedia release go to:
https://www.multivu.com/players/English/8039752-toys-r-us-2017-holiday-hot-toy-list/
Each day in the U.S. 91 people die from an opioid-related overdose, and the numbers are increasing. In observance of International Overdose Awareness Day on August 31, American Addiction Centers (AAC) and Recovery Brands are launching a nationwide awareness campaign on how to prevent deaths from opioid overdoses. The campaign features shareable online resources, including an animation video about how an overdose impacts a body, an infographic about how to administer overdose medication, and powerful videos of survivors sharing the life-saving lessons they learned during their darkest hours.
“This is a meaningful endeavor as we partner with our parent company, AAC, in order to present several life-saving resources for people impacted by addiction,” said Ruchi Dhami, director of market insights and development at Recovery Brands, a provider of digital addiction treatment resources. “Since such a large amount of individuals look for information online about addiction and treatment, we wanted to ensure comprehensive education surrounding opioid overdoses existed and is easily accessible for individuals and families impacted by addiction.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8130951-american-addiction-centers-opioid-overdose/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Allergan plc (NYSE:AGN), a global leader in eye care for nearly 70 years, today unveiled #EyePic, an exciting new online awareness campaign as part of the See America initiative to fight preventable blindness and visual impairment in the United States. #EyePic will use the power of social media to broaden awareness of preventable blindness, promote discussion around eye health and ultimately encourage all Americans to visit their eye doctors for comprehensive eye exams.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134051-allergan-see-america-eyepic-campaign/
Millions of children in the United States don’t have health coverage. As a result, it may be difficult or impossible for them to get the routine preventive care that keeps them healthy or access to the care they need if they get sick or injured. But, the majority of the nation’s uninsured children are eligible for free or low-cost health coverage through their state Medicaid or Children’s Health Insurance Program (CHIP). They can apply for the comprehensive benefits these programs provide at any time, and now the enrollment process is faster.
To view the multimedia release go to:
https://www.multivu.com/players/English/8102651-hhs-connecting-kids-to-coverage-psa-insurekidsnow/
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
